Unit Two: Cancer Biology and Genetics

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Understanding the biology and genetics of cancer is crucial for the development of effective prevention, diagnosis, and treatment strategies. In this explanation, we will discuss key terms and vocabulary related to Unit Two: Cancer Biology and Genetics in the Certified Specialist Programme in Integrative Oncology.

1. Oncogenes and Tumor Suppressor Genes

Oncogenes are genes that promote cell growth and division, while tumor suppressor genes regulate and inhibit cell growth. Mutations in oncogenes can lead to uncontrolled cell growth, while mutations in tumor suppressor genes can lead to a loss of cell growth regulation.

2. Genetic and Epigenetic Changes

Genetic changes refer to alterations in the DNA sequence, while epigenetic changes refer to modifications in gene expression without alterations in the DNA sequence. Both genetic and epigenetic changes can contribute to the development and progression of cancer.

3. Carcinogens

Carcinogens are substances that can cause cancer. They can be physical (e.g., radiation), chemical (e.g., tobacco smoke), or biological (e.g., viruses).

4. Multistep Carcinogenesis

Multistep carcinogenesis is the process by which normal cells transform into cancer cells through a series of genetic and epigenetic changes. This process typically involves the accumulation of multiple mutations in oncogenes and tumor suppressor genes.

5. Angiogenesis

Angiogenesis is the formation of new blood vessels. In cancer, angiogenesis is critical for the growth and spread of tumors, as it provides nutrients and oxygen to the tumor cells.

6. Metastasis

Metastasis is the spread of cancer cells from the primary tumor to other parts of the body. This occurs through the lymphatic system or bloodstream, and can result in the formation of secondary tumors.

7. Apoptosis

Apoptosis is programmed cell death, which is a normal process that helps to maintain tissue homeostasis. In cancer, apoptosis is often impaired, leading to the accumulation of abnormal cells.

8. Genomic Instability

Genomic instability is the increased tendency for genetic mutations to occur. This is a characteristic feature of cancer cells, and can contribute to their uncontrolled growth and spread.

9. Microsatellite Instability (MSI)

Microsatellite instability (MSI) is a form of genomic instability that occurs due to defects in the DNA mismatch repair system. MSI is a characteristic feature of some types of cancer, such as colorectal cancer.

10. Chromosomal Instability (CIN)

Chromosomal instability (CIN) is a form of genomic instability that occurs due to abnormalities in chromosome number or structure. CIN is a characteristic feature of some types of cancer, such as colorectal cancer.

11. DNA Methylation

DNA methylation is an epigenetic modification that involves the addition of a methyl group to the DNA molecule. DNA methylation can lead to the silencing of tumor suppressor genes, which can contribute to the development and progression of cancer.

12. Histone Modifications

Histone modifications are epigenetic modifications that involve the modification of histone proteins, which are involved in the packaging of DNA. Histone modifications can affect gene expression, and have been implicated in the development and progression of cancer.

13. MicroRNAs (miRNAs)

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by binding to messenger RNAs (mRNAs). miRNAs have been implicated in the development and progression of cancer, and can function as oncogenes or tumor suppressor genes.

14. Long Non-coding RNAs (lncRNAs)

Long non-coding RNAs (lncRNAs) are non-coding RNAs that are greater than 200 nucleotides in length. lncRNAs regulate gene expression and have been implicated in the development and progression of cancer.

15. Circular RNAs (circRNAs)

Circular RNAs (circRNAs) are non-coding RNAs that form a circular structure. circRNAs regulate gene expression and have been implicated in the development and progression of cancer.

16. Epigenetic Therapy

Epigenetic therapy is a type of cancer treatment that targets epigenetic modifications. This includes drugs that inhibit DNA methylation or histone modifications, and can lead to the re-expression of tumor suppressor genes.

17. Immunotherapy

Immunotherapy is a type of cancer treatment that uses the immune system to fight cancer. This includes drugs that activate the immune system, such as checkpoint inhibitors, and cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy.

18. Targeted Therapy

Targeted therapy is a type of cancer treatment that targets specific molecular pathways or cellular processes that are involved in the development and progression of cancer. This includes drugs that target oncogenes or tumor suppressor genes, and drugs that inhibit angiogenesis.

19. Precision Medicine

Precision medicine is a personalized approach to cancer treatment that takes into account the individual genetic and molecular characteristics of each patient's tumor. This allows for the development of targeted therapies that are more effective and less toxic than traditional cancer treatments.

20. Liquid Biopsy

A liquid biopsy is a non-invasive test that analyzes cancer-related molecules in bodily fluids, such as blood or urine. Liquid biopsies can be used to detect cancer at an early stage, monitor disease progression, and assess response to treatment.

In conclusion, understanding the biology and genetics of cancer is crucial for the development of effective prevention, diagnosis, and treatment strategies. Key terms and vocabulary related to cancer biology and genetics include oncogenes and tumor suppressor genes, genetic and epigenetic changes, carcinogens, multistep carcinogenesis, angiogenesis, metastasis, apoptosis, genomic instability, microsatellite instability (MSI), chromosomal instability (CIN), DNA methylation, histone modifications, microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), epigenetic therapy, immunotherapy, targeted therapy, precision medicine, and liquid biopsy. Understanding these concepts can help healthcare professionals to provide better care for patients with cancer, and can contribute to the development of new and more effective cancer treatments.